Smart bottle cap could reveal hidden missed doses in GERD patients

NCT ID NCT07712614

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests whether a digital bottle cap called FORTISKAP™ can detect missed doses of proton pump inhibitors (PPIs) in people with GERD more accurately than standard methods like pharmacy fill records or patient questionnaires. Fifty adults with GERD who take a daily PPI will use the cap for 90 days, which records each bottle opening. The goal is to see if real-time tracking catches non-adherence that other measures miss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fortiskap bottle-top medication monitor (a digital cap that records bottle openings)
What this could lead to
If successful, this device could give doctors a more accurate way to spot when patients skip their GERD medication, potentially improving treatment outcomes.
What could go wrong
This is a small, early study (50 people) comparing a device to existing methods, not testing a new treatment. The device may not work for everyone or may be inconvenient to use long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EROSIVE ESOPHAGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tidal Health

    Salisbury, Maryland, 21801, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.